ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 29 | July 16, 2004

Download PDF Visit The Full Archive

Related Articles

Tasigna Shows High Response, PFS Benefit Compared to Gleevec in Phase III CML Study

December 26, 2014

Natcher Subcommittee Kills Recision, Save NCI $17 Million

May 2, 1980

Cigarette use declining among high school students, report finds.

June 25, 2004

President’s Budget: $64 Million Cut for NCI, No Start On Year 2000 goals, Drop 240 Grants In 1985

February 8, 1985

ODAC Votes Against Adria’s Chemoprotector, Okays Leustatin

July 3, 1992

EORTC Places Same Number on Phase 2-3 Trials As In U.S.

December 12, 1986